Buy Merck – Book profit if breaks 4150 (now Procter and Gamble Health)
Current market price: 847.35. Long term target: 1695. Book value: 315.09. P/E ratio: 28.08 – (Book profit if breaks 4150 (now Procter and Gamble Health))
Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. Around 39,000 employees work in 66 countries to improve the quality of life for patients, to further the success of our customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company. Since 1668 our name has stood for innovation, business success and responsible entrepreneurship. The founding family remains the majority owner of the company to this day. We are Merck, the original, and hold the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where we are known as EMD.
Merck – a quality brand that creates and enjoys trust worldwide. Even if it’s not found in any balance sheet, the Merck brand is still one of our most important assets. Since Friedrich Jacob Merck laid the foundation stone in 1668, the name Merck has stood for medicines and chemical products that have proved invaluable to people and have created inestimable value for the company.
Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967. The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Never stop learning. That’s the only way. To this day, we derive our power to grow from the balance between the old and the new, between tradition and innovation. The Merck Way – or the secret as to how a company has managed to remain successful in the marketplace even after more than 340 years – is based on three principles: Sustain. Change. Grow.
Reliable owners: There’s nothing better than strong roots. Our ownership structure allows us to unite two often contradictory entrepreneurial qualities — speed and sustainability.
Businesses:
Merck Serono – Transforming lives through medical science
Merck Serono is the largest division of Merck. It markets innovative prescription drugs of chemical and biotechnological origin. Merck Serono focuses on highly specialized therapeutic areas such as Neurodegenerative Diseases, Oncology, Fertility, Endocrinology and Rheumatology.
Consumer Health – Reach for a better life!
The Consumer Health division offers high-quality over-the-counter products to enhance the quality of life of consumers all over the world. Our brands are available in many countries in Europe, North and South America, Asia and Africa.
Performance Materials – Experience Innovation
Merck’s Performance Materials division offers highly innovative materials, advanced technologies, and high-tech chemicals to clients in the consumer electronics, lighting, printing, plastics, and cosmetics industries. Our market leader products include liquid crystals for LCD displays, new lighting technologies, and functional and effect pigments.
Merck Millipore – Advancing Life Science Together
Our Merck Millipore division offers solutions that enable scientists to conduct life science research easily, efficiently and economically. With a range of more than 40,000 products, Merck Millipore is one of the top three suppliers of tools to the life science industry. The division comprises three business units: Bioscience, Lab Solutions and Process Solutions.
SMS Alerts, no more page refreshes required
44 Responses
{ ADD YOUR OWN }Leave a Reply
Subscribe to Comments feedLatest Query
- by Sam
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis
Rahul Kumar Sinha Says:
September 22nd, 2014
Posted at: 1:35 am
what is the time horizon for this target?One to two years?
CB Says:
September 22nd, 2014
Posted at: 6:53 am
Hi Rahul Kumar Sinha, its a hold for 1-2 years.
Pradeep Says:
September 22nd, 2014
Posted at: 8:18 am
How abt if we hold STEL holding having investment in quoted shares around 120/- per share and in pipeline of listing unquoted share cumulative future quoted investment come around 200/- per share
Trading around 30/-
Is it good idea to accumulate for Long Term
CB Says:
September 22nd, 2014
Posted at: 8:29 am
Hi Pradeep, what is the bse code for STEL holdings?
Pradeep Says:
September 22nd, 2014
Posted at: 8:31 am
For STEL Holding BSE Code 533316
CB Says:
September 22nd, 2014
Posted at: 8:33 am
Hi Pradeep, Yes, it does look good for long term. can add few here.
Pradeep Says:
September 22nd, 2014
Posted at: 8:36 am
My worry is even having good investment stock price is quoted around 30/-, there are so many stocks which are good but market price trade low all the time.
Can you suggest based on the fact of investment and its trading volumes what target we can expect
CB Says:
September 22nd, 2014
Posted at: 8:40 am
Hi Pradeep, can test 45 levels in med/ lng term. hold onto it.
Rahul kumar sinha Says:
September 22nd, 2014
Posted at: 10:17 am
thanks cb as always.
I sold lupin ten shares of lupin bought at 600 and purchased twenty shares of merck as lupin already rallied more than 100 percent.
CB Says:
September 22nd, 2014
Posted at: 10:52 am
Hi Rahul kumar sinha, most welcome..yes, lupin has rallied quite a bit already.
Rahul Kumar Sinha Says:
September 22nd, 2014
Posted at: 2:58 pm
how do you find indraprastha medical corporation from one to two years perspective..one of my friend suggested that it can cross 100..what's your view.I cannot trust anyopne but you :).Please suggest
CB Says:
September 22nd, 2014
Posted at: 10:03 pm
Hi Rahul Kumar Sinha, its likely to move with the markets. it has sizable debt. also profits have not really been increasing YoY. fundamentally its a sound bet. if already holding, would advice to hold onto it. technically too is in an uptrend as of now. best to hold with a trailing sl if in profits.
Rahul Kumar Sinha Says:
September 23rd, 2014
Posted at: 1:16 am
i haven't bought it..needed your advice if i can make a fresh entry and if yes then at what price i should enter and stop loss and target price in one to two years?
CB Says:
September 23rd, 2014
Posted at: 8:17 am
Hi Rahul Kumar Sinha, can add 50% on dips near 52 for now.